DIVIS LABORATORIES
|
The Current P/S Ratio of DIVIS LABORATORIES is 16.03.
| Share Price | ₹6,054.3 | Jan 30,2026 |
| Market Cap | ₹160,740.3 Cr | |
| Sales-TTM | ₹10,029.0 Cr | TTM-Consolidated Results |
| Price/Sales | 16.03x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of DIVIS LABORATORIES
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹160,740.3 Cr] as on Jan 30,2026
(/) Sales [ ₹10,029.0 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 16.03x ]
Thus, for DIVIS LABORATORIES , the investors are currently willing to pay '16.03 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of DIVIS LABORATORIES !
The chart below summarizes the trend in P/S Ratio of DIVIS LABORATORIES over the last five years.
Historical PS (Price/Sales) ratio chart of DIVIS LABORATORIES
PS Ratio Performance Analysis for DIVIS LABORATORIES
- DIVIS LABORATORIES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 12.89x.
- DIVIS LABORATORIES 's operated at median p/e ratio of 13.05x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, DIVIS LABORATORIES 's p/e ratio peaked in Mar2025 at 16.34x.
- DIVIS LABORATORIES 's p/e ratio hit its five-year low in Mar2023 of 9.64x.
How does DIVIS LABORATORIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| DIVIS LABORATORIES | 10,029.0 | 16.03 | 160,740.3 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 54,964.0 | 6.96 | 382,694.0 |
| CIPLA LTD | 28,351.1 | 3.77 | 106,946.0 |
| TORRENT PHARMACEUTICALS LTD | 12,248.0 | 10.94 | 134,016.0 |
| DR REDDYS LABORATORIES LTD | 34,682.2 | 2.93 | 101,691.0 |
| MANKIND PHARMA LTD | 13,576.9 | 6.46 | 87,717.0 |
| ZYDUS LIFESCIENCES LTD | 24,493.9 | 3.64 | 89,071.8 |
| LUPIN LTD | 24,750.7 | 3.97 | 98,296.1 |
| AUROBINDO PHARMA LTD | 32,514.5 | 2.17 | 70,410.6 |
| ABBOTT INDIA LTD | 6,714.4 | 8.76 | 58,807.4 |
| ALKEM LABORATORIES LTD | 13,890.2 | 4.88 | 67,828.6 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs DIVIS LABORATORIES 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.17x |
| Max industry PS | 16.03x |
| Median industry PS | 4.88x |
| Average industry PS | 6.41x |
You may also like the below Video Courses